Meklēt

Meklēšanas rezultāti

Tiek rādīts Nr. 10 no 82 rezultāti

On 11 November 2020, the European Commission put forward a proposal for a regulation on serious cross-border threats to health. In the light of lessons learned from the coronavirus crisis, it aims to strengthen the EU's health security by revising Decision 1082/2013/EU (the 'Cross-Border Health Threats Decision'). The proposal was presented in a package that also includes proposals to strengthen the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA), ...

On 11 November 2020, the European Commission adopted a proposal on serious cross-border threats to health. The proposed regulation aims to strengthen existing structures and mechanisms for better protection, prevention, preparedness and response against all health hazards at EU level. The European Parliament's Committee on the Environment, Public Health and Food Safety adopted its report on 13 July 2021. This is due to be voted during the September plenary session, thus setting Parliament's negotiating ...

On 11 November 2020, the European Commission adopted a proposal to bolster the mandate of the European Centre for Disease Prevention and Control (ECDC), with a view to improving the EU's capacity to anticipate, prepare for and manage future cross-border health threats. The European Parliament's Committee on the Environment, Public Health and Food Safety adopted its report on 29 June 2021. This is due to be voted during the September plenary session, thus setting Parliament's negotiating position ...

The European Commission has proposed a regulation on health technology assessment (HTA). HTA is a research-based tool that supports decision-making in healthcare by assessing the added value of a given health technology compared to others. The proposal would provide the basis for permanent EU-level cooperation in four areas. Member States would still be responsible for assessing the non-clinical (economic, ethical, social, etc.) aspects of health technology, and for pricing and reimbursement. While ...

Mental health and the pandemic

Briefing 09-07-2021

While the pandemic is primarily a physical health crisis, it has also had widespread impact on people's mental health, inducing, among other things, considerable levels of fear, worry, and concern. The growing burden on mental health has been referred to by some as the 'second' or 'silent' pandemic. While negative mental health consequences affect all ages, young people, in particular, have been found to be at high risk of developing poor mental health. Specific groups have been particularly hard ...

On 11 November 2020, the European Commission adopted a proposal to strengthen the European Medicines Agency (EMA). The proposed regulation would allow the EMA, among other things, to better anticipate possible shortages of medicinal products and ensure their timely development, with the aim of improving the EU's capacity to respond to health emergencies. The European Parliament's Committee on the Environment, Public Health and Food Safety adopted its report on 22 June 2021. This is due to be voted ...

Global Health Summit

Pārskats 12-05-2021

The Global Health Summit – jointly hosted by the European Commission and Italy, as chair of the Group of Twenty (G20) – will take place on 21 May 2021 in Rome. Bringing together leaders, heads of international and regional organisations and representatives of global health bodies, it will provide a platform for sharing lessons learned from the coronavirus pandemic. The discussions will feed into a declaration of principles that can guide multilateral cooperation and joint action to prevent future ...

EU4Health programme

Briefing 22-04-2021

On 28 May 2020, the European Commission adopted a proposal for a regulation on a new health programme (EU4Health) for 2021 to 2027. Announced as part of the Next Generation EU (NGEU) recovery instrument, according to the Commission, the EU4Health programme is intended to boost the EU's preparedness for major cross-border health threats and improve health systems' resilience. EU4Health would be a stand-alone, dedicated funding programme with an originally proposed budget of €10.4 billion (in current ...

The European Commission has proposed to amend Directive 2004/37/EC, by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The initiative is proceeding in steps and has now become a continuous process. Following on from three previous legislative amendments, which covered a total of 26 priority chemical agents, the present (fourth) proposal addresses an additional three. The proposal was announced as ...

On 3 February 2021, the European Commission presented Europe's Beating Cancer plan, slightly delayed on account of the pandemic. The plan is a key European Union (EU) public health initiative and a cornerstone of the European health union process launched in November 2020. Responsibility for health lies primarily with the governments of the individual EU Member States. Europe's Beating Cancer plan sets out actions to support, coordinate or supplement Member States' efforts at every stage of the disease ...